Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches.

Ravinder Claire, Tim Coleman, Jo Leonardi-Bee, Ivan Berlin
Author Information
  1. Ravinder Claire: Division of Primary Care, University of Nottingham, Nottingham, UK. ORCID
  2. Tim Coleman: Division of Primary Care, University of Nottingham, Nottingham, UK. ORCID
  3. Jo Leonardi-Bee: Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK. ORCID
  4. Ivan Berlin: Département de pharmacologie, Hôpital Pitié-Salpêtrière, Paris, France. ORCID

Abstract

BACKGROUND AND AIMS: Due to concerns about increased exposure to nicotine, pregnant women using nicotine replacement therapy (NRT) to stop smoking are usually advised to stop using NRT if they relapse to smoking. This study investigated whether this is justified. We compared changes in saliva cotinine from baseline to 2 weeks post-target quit date pregnant smokers who relapsed to smoking and continued to use their patches having been assigned to use nicotine patches or placebo.
DESIGN AND SETTING: Controlled pre-post design stratified by intervention condition from the 'Study of Nicotine Patch in Pregnancy', a randomized, placebo-controlled trial.
PARTICIPANTS: A sample of 268 pregnant women, assigned placebo (n = 122) or nicotine (n = 146) patches, who returned for further supplies of patches and who reported any smoking in the week prior to a visit at 2 weeks after their target quit date.
MEASUREMENTS: Saliva cotinine concentrations were measured at baseline and 2 weeks after participants' target quit dates. Any smoking in the previous week was assessed by self-report, validated by expired air carbon monoxide (CO).
FINDINGS: There was no change in saliva cotinine concentrations between baseline and 2 weeks post-target quit date in saliva cotinine concentration in the nicotine patch group [ratio of geometric means = 0.94, 95% confidence interval (CI) = 0.83 to 1.07; P = 0.37, Bayes factor = 0.15]. However, there was a reduction in reported number of cigarettes smoked/day (mean difference -6, 95% CIs -7 to -5, P < 0.001) and in CO concentrations (mean difference -3.0 parts per million, 95% CIs -4.2 to -1.9, P < 0.001). These changes were not significantly different from changes in the placebo group except for cigarette consumption, which reduced more in the nicotine group (P = 0.046).
CONCLUSIONS: In women trying to stop smoking with the aid of a nicotine patch but having smoked at 2 weeks post-target quit, their nicotine concentration did not change from baseline, but they reported smoking fewer cigarettes and had lower carbon monoxide concentrations.

Keywords

References

  1. BMJ. 2014 Mar 11;348:g1622 [PMID: 24627552]
  2. Obstet Gynecol. 2003 Jan;101(1):140-7 [PMID: 12517659]
  3. Pediatrics. 2008 Sep;122(3):e643-7 [PMID: 18762498]
  4. J Pharmacol Exp Ther. 2002 May;301(2):594-8 [PMID: 11961061]
  5. Cochrane Database Syst Rev. 2015 Dec 22;(12):CD010078 [PMID: 26690977]
  6. MMWR Surveill Summ. 2013 Nov 8;62(6):1-19 [PMID: 24196750]
  7. Addiction. 2012 Jul;107(7):1349-53 [PMID: 22276996]
  8. Br J Addict. 1991 Sep;86(9):1119-27 [PMID: 1932883]
  9. Clin Pharmacol Ther. 2004 Jul;76(1):64-72 [PMID: 15229465]
  10. Addiction. 2019 Mar;114(3):406-424 [PMID: 30315598]
  11. Paediatr Perinat Epidemiol. 2005 Sep;19(5):368-76 [PMID: 16115289]
  12. Nicotine Tob Res. 2016 Apr;18(4):477-83 [PMID: 25995159]
  13. Nicotine Tob Res. 2002 May;4(2):149-59 [PMID: 12028847]
  14. Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146 [PMID: 23152200]
  15. Lancet. 2016 Feb 13;387(10019):691-702 [PMID: 26794070]
  16. Addiction. 2015 Nov;110(11):1827-32 [PMID: 26119134]
  17. N Engl J Med. 2012 Mar 1;366(9):808-18 [PMID: 22375972]
  18. PLoS One. 2014 Nov 18;9(11):e113045 [PMID: 25405343]
  19. Addiction. 2019 Sep;114(9):1651-1658 [PMID: 31106486]
  20. Am J Epidemiol. 2014 Apr 1;179(7):807-23 [PMID: 24518810]

MeSH Term

Adult
Breath Tests
Carbon Monoxide
Cigarette Smoking
Cotinine
Female
Humans
Nicotine
Nicotinic Agonists
Pregnancy
Pregnancy Complications
Recurrence
Saliva
Smoking Cessation
Smoking Reduction
Tobacco Use Cessation Devices
Young Adult

Chemicals

Nicotinic Agonists
Nicotine
Carbon Monoxide
Cotinine

Word Cloud

Created with Highcharts 10.0.0nicotinesmokingcotinine2 weeksquitpatchesconcentrationspregnantwomenbaselinestopchangessalivapost-targetdateuseplaceboreportedgroup95%ANDusingreplacementtherapyNRTassignedweektargetSalivacarbonmonoxideCOchangeconcentrationpatchP = 0cigarettesmeanP < 0001BACKGROUNDAIMS:DueconcernsincreasedexposureusuallyadvisedrelapsestudyinvestigatedwhetherjustifiedcomparedsmokersrelapsedcontinuedDESIGNSETTING:Controlledpre-postdesignstratifiedinterventioncondition'StudyNicotinePatchPregnancy'randomizedplacebo-controlledtrialPARTICIPANTS:sample268n = 122n = 146returnedsuppliespriorvisitMEASUREMENTS:measuredparticipants'datespreviousassessedself-reportvalidatedexpiredairFINDINGS:[ratiogeometricmeans = 094confidenceintervalCI = 08310737Bayesfactor = 015]Howeverreductionnumbersmoked/daydifference -6CIs -7-5difference -30 partspermillionCIs -42-19significantlydifferentexceptcigaretteconsumptionreduced046CONCLUSIONS:tryingaidsmokedfewerlowersmokeCotininepregnancycessation

Similar Articles

Cited By